Vistin Pharma ASA announced that it has entered into a long-term industrial energy agreement with Statkraft, The agreement will secure a significant part of Vistin's electricity demand on competitive terms until 2032. The agreement
includes Guarantees of Origin as certification of the renewable energy supply, and starts 1.1.2023. 2022 has been very challenging for Vistin and the Norwegian industry, when it comes to electricity costs, with extreme volatility and record high electricity prices in the NO2 area where Vistin's fully automated production plant is located.